Sirtex Medical Limited Given Hold Rating at Morningstar (SRX)
Sirtex Medical Limited (ASX:SRX)‘s stock had its “hold” rating reaffirmed by stock analysts at Morningstar in a report issued on Friday, AnalystRatings.Net reports.
Separately, analysts at CIMB reiterated a “reduce” rating on shares of Sirtex Medical Limited in a research note on Sunday, January 26th.
Sirtex Medical Limited (ASX:SRX) opened at 15.460 on Friday. Sirtex Medical Limited has a one year low of A$9.540 and a one year high of A$16.430. The stock has a 50-day moving average of A$15.71 and a 200-day moving average of A$13.51. The company has a market cap of A$867.4 million and a price-to-earnings ratio of 41.42.
Sirtex Medical Limited is a biotechnology and medical device company. The Company is engaged in manufacturing and to distribute liver cancer treatments utilizing particle technology to approved markets in Asia-Pacific, Europe and the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.